REG - British Amer.Tobacco - BAT Appoints Chief People Officer

British American TobaccoAnnouncement

13/10/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231013:nRSM9930Pa&default-theme=true

RNS Number : 9930P  British American Tobacco PLC  13 October 2023

British American Tobacco p.l.c. (the "Company")

13 October 2023

BAT Appoints Chief People Officer to the Management Board

Further to the changes to the Management Board announced on 19 June 2023, Cora
Koppe-Stahrenberg, has been appointed to the new role of Chief People Officer
and will join the BAT Management Board with effect from 1 November 2023.

Bringing critical experiences from other sectors and industries, Cora was most
recently Global Head of Human Resources of Fresenius Medical Care, a publicly
listed global healthcare company with over 125,000 employees. While at
Fresenius Medical Care, Cora established a new Global HR function, and
implemented a global people strategy which focused on the creation of a
collaborative and empowering culture delivered through a number of change
initiatives. Previously, Cora held various international senior HR positions
at Marsh & McLennan Companies, Emirates Investment Authority, and General
Electric.

Tadeu Marroco, Chief Executive, commented:

"I am delighted to welcome Cora to the Management Board. This is a significant
management team enhancing appointment for BAT. Culture and collaboration are
at the heart of my leadership agenda, Cora shares these values and will play a
key role in the Group's transformation to build A Better Tomorrow.  I have no
doubt that Cora will bring a fresh perspective having worked internationally
in multiple sectors outside our industry and will bring new insights and
capability to our management team.

"I look forward to working with Cora to deliver a winning culture and a
dynamic, modern BAT."

The Chief People Officer will report to the Chief Executive.

ENDS
Enquiries

Media Centre

+44 (0) 20 7845 2888 (24 hours) | @BATplc (https://twitter.com/BATplc)

Investor Relations

Victoria Buxton: +44 (0)20 7845 2012

Amy Chamberlain: +44 (0)20 7845 1124

Yetunde Ibe: +44 (0)20 7845 1095

John Harney: +44 (0)20 7845 1263

Jane Henderson: +44 (0)20 7845 1117

About BAT

BAT is a leading, multi-category consumer goods business with a purpose to
build A Better Tomorrow™ by reducing the health impact of its business
through offering a greater choice of enjoyable and less risky products for
adult consumers.

We continue to be clear that combustible cigarettes pose serious health risks,
and the only way to avoid these risks is not to start or to quit. BAT
encourages those who would otherwise continue to smoke to switch completely to
scientifically-substantiated, reduced-risk alternatives*†. In order to
deliver this, BAT is transforming into a truly consumer-centric multi-category
consumer products business.

BAT's ambition is to have 50 million consumers of its non-combustible products
by 2030 and to generate £5billion of New Categories revenue by 2025. BAT has
set stretching ESG targets including achieving carbon neutrality for Scopes 1
& 2 by 2030 and eliminating unnecessary single-use plastic and making all
plastic packaging reusable, recyclable or compostable by 2025.

BAT employs over 50,000 people. The BAT Group generated revenue of £27.65
billion in 2022 and profit from operations of £10.5 billion.

The company's Strategic Portfolio is made up of its global cigarette brands
and a growing range of reduced-risk*† New Category tobacco and nicotine
products and traditional non-combustible tobacco products. These include
vapour, tobacco heating products, modern oral products including tobacco-free
nicotine pouches, as well as traditional oral products such as snus and moist
snuff. In 2022, we had 22.5 million consumers of our non-combustible products,
a rise of 4.2 million on full year 2021.

References in this statement to 'BAT', 'we', 'us' and 'our' refer to the
British American Tobacco Group.

* Based on the weight of evidence and assuming a complete switch from
cigarette smoking. These products are not risk free and are addictive.

† Our vapour product Vuse (including Alto, Solo, Ciro and Vibe), and
certain products, including Velo, Grizzly, Kodiak, and Camel Snus, which are
sold in the U.S., are subject to FDA regulation and no reduced-risk claims
will be made as to these products without agency clearance.

Forward-looking statements

This release contains certain forward-looking statements, including
"forward-looking" statements made within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995. These statements are often, but not
always, made through the use of words or phrases such as "believe,"
"anticipate," "could," "may," "would," "should," "intend," "plan,"
"potential," "predict," "will," "expect," "estimate," "project," "positioned,"
"strategy," "outlook", "target" and similar expressions. These include
statements regarding our customer target ambition, New Categories revenue
targets and our ESG targets.

All such forward-looking statements involve estimates and assumptions that are
subject to risks, uncertainties and other factors. It is believed that the
expectations reflected in this release are reasonable but they may be affected
by a wide range of variables that could cause actual results to differ
materially from those currently anticipated. A review of the reasons why
actual results and developments may differ materially from the expectations
disclosed or implied within forward-looking statements can be found by
referring to the information contained under the headings "Cautionary
Statement" and "Group Principal Risks" in the 2022 Annual Report and Form 20-F
of British American Tobacco p.l.c. (BAT PLC).

Additional information concerning these and other factors can be found in BAT
PLC's filings with the U.S. Securities and Exchange Commission ("SEC"),
including the Annual Report on Form 20-F and Current Reports on Form 6-K,
which may be obtained free of charge at the SEC's website, http://www.sec.gov
and BAT PLC's Annual Reports, which may be obtained free of charge from the
BAT website www.bat.com (http://www.bat.com/) .

Past performance is no guide to future performance and persons needing advice
should consult an independent financial adviser. The forward-looking
statements reflect knowledge and information available at the date of
preparation of this release and BAT undertakes no obligation to update or
revise these forward-looking statements, whether as a result of new
information, future events or otherwise. Readers are cautioned not to place
undue reliance on such forward-looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAFLFFDIVLFLIV